In skin cancers and other solid tumors of barrier tissues, TRM are present as CD8+CD103+CD49a+ tumor‐infiltrating lymphocytes with effector (memory) functions138 and are generally associated with good outcomes.139, 140. The gene discussed is CD8A; the disease is neoplasm.